Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study, performed under GLP conditions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1997
Report date:
1997

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
Also EC Guideline 96/54/EEC
GLP compliance:
yes (incl. QA statement)
Type of study:
Buehler test

Test material

Constituent 1
Chemical structure
Reference substance name:
Nicotinonitrile
EC Number:
202-863-0
EC Name:
Nicotinonitrile
Cas Number:
100-54-9
Molecular formula:
C6H4N2
IUPAC Name:
pyridine-3-carbonitrile
Constituent 2
Reference substance name:
Pyridine-3-carbonitrile
IUPAC Name:
Pyridine-3-carbonitrile

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Hartley HsdPOC: DH
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
0.5 ml
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
0.5 ml
No. of animals per dose:
20
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0.5 ml water
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No erythema or edema
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0.5 ml water. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No erythema or edema.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0.5 ml water
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No eythema or edema
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0.5 ml water. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No eythema or edema.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.5 ml
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no erythema or edema
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5 ml. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no erythema or edema.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0.5 ml
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No erythema or edema
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5 ml. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No erythema or edema.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
3-Cyanopyridine was tested in guinea pigs for sensitisation following occlusive dermal exposure. The substance was found to be non-sensitising.